Jacques Feldmar
Direktor/Vorstandsmitglied bei OBS Medical Ltd.
Profil
Dr. Jacques Feldmar is a Director-International Marketing at Intrasense SA.
He received his doctorate degree from the Institut National de Recherche en Informatique et en Automati and a doctorate degree from Ecole Polytechnique.
Aktive Positionen von Jacques Feldmar
Unternehmen | Position | Beginn |
---|---|---|
OBS Medical Ltd.
OBS Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology OBS Medical Ltd. manufactures and distributes physiological monitoring and patient monitoring devices. Its product Visensia, a physiological monitoring system for detecting early clinical patient deterioration. The firm operates as a predictive software company that provides products and services for the hospital, community and consumer health care markets. It develops and support products that enable their customers, both patients and healthcare professionals, to manage and monitor health conditions more effectively through simplification, risk identification and prevention. The company was founded in 2000 and is headquartered in Abingdon, the United Kingdom. | Direktor/Vorstandsmitglied | 05.06.2018 |
Ehemalige bekannte Positionen von Jacques Feldmar
Unternehmen | Position | Ende |
---|---|---|
INTRASENSE | Vertrieb & Marketing | - |
Ausbildung von Jacques Feldmar
Institut National de Recherche en Informatique et Automatique | Doctorate Degree |
Ecole Polytechnique | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
INTRASENSE | Technology Services |
Private Unternehmen | 1 |
---|---|
OBS Medical Ltd.
OBS Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology OBS Medical Ltd. manufactures and distributes physiological monitoring and patient monitoring devices. Its product Visensia, a physiological monitoring system for detecting early clinical patient deterioration. The firm operates as a predictive software company that provides products and services for the hospital, community and consumer health care markets. It develops and support products that enable their customers, both patients and healthcare professionals, to manage and monitor health conditions more effectively through simplification, risk identification and prevention. The company was founded in 2000 and is headquartered in Abingdon, the United Kingdom. | Electronic Technology |